News of the WeekU.S. BIOMEDICAL POLICY

Acting FDA Head Drops NCI Post

+ See all authors and affiliations

Science  07 Oct 2005:
Vol. 310, Issue 5745, pp. 29
DOI: 10.1126/science.310.5745.29

You are currently viewing the summary.

View Full Text

Summary

Trying to calm an uproar after he took a second job, the chief of the U.S. National Cancer Institute (NCI) declared last week that he would take a leave of absence while he serves as acting commissioner of the Food and Drug Administration (FDA).